Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GDA | Q9Y2T3 | 1/20 | 0.63 |
| ▸ | PNP | P00491 | 1/20 | 0.62 |
| ▸ | XDH | P47989 | 3/20 | 0.58 |
| ▸ | POLA1 | P09884 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22885 | 0.83 | GDA (0.68) | GDAPNPXDHPOLA1 | |
| SCHEMBL2051369 | 0.83 | GDA (0.63) | GDAPNPXDHPOLA1 | |
| SCHEMBL29407603 | 0.83 | GDA (0.63) | GDAPNPXDHPOLA1 | |
| SCHEMBL2983854 | 0.83 | GDA (0.68) | GDAPNPXDHPOLA1 | |
| SCHEMBL852109 | 0.83 | GDA (0.63) | GDAPNPXDHPOLA1 | |
| SCHEMBL1843779 | 0.83 | GDA (0.63) | GDAPNPXDHPOLA1 | |
| SCHEMBL20580 | 0.83 | GDA (0.63) | GDAPNPXDHPOLA1 | |
| SCHEMBL8886042 | 0.83 | GDA (0.63) | GDAPNPXDHPOLA1 | |
| Aspartic Acid SCHEMBL1519000 | 0.82 | GDA (0.52) | GDAPNPXDH | |
| SCHEMBL5935074 | 0.81 | XDH (0.78) | GDAPNPXDHPOLA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 345 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111333649-B | SNAP-tag technology-based cell membrane fluorescent probe and preparation and application thereof | 中国科学院大连化学物理研究所 | 2022-06-03 | — | — | CN | claimed |
| CN-101784556-B | Thiocarbon-protecting groups for rna synthesis | AGILENT TECHNOLOGIES INC | 2014-07-09 | — | — | CN | claimed |
| CN-103476947-A | Enhanced biodistribution of oligomers | GROOVE BIOPHARMA CORP | 2013-12-25 | — | — | CN | claimed |
| CN-103068834-A | Phosphoramidites for reverse RNA synthesis | CHEMGENES CORP | 2013-04-24 | — | — | CN | claimed |
| CN-102766182-A | Method for synthesizing dideoxynucleoside through glycosyl transfer reaction and application thereof | JIANGYIN SULI CHEMICAL CO LTD | 2012-11-07 | — | — | CN | claimed |
| CN-1189562-C | Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase | GENESENSE TECHNOLOGIES INC (CA) | 2005-02-16 | — | — | CN | claimed |
| CN-1160402-A | Purine and guanine compounds as inhibitors of PNP | CHIROSCIENCE LTD (GB) | 1997-09-24 | — | — | CN | claimed |
| EP-4698674-A1 | METHODS TO TREAT GLIOMA IN SUBJECTS WITH DEFINED TUMOUR MICROENVIRONMENT | University Health Network (CA) | 2026-02-25 | — | — | EP | disclosed |
| US-20260049318-A1 | INHIBITION OF PLANT PROTEASE AED3-1 FOR IMPROVED HETEROLOGOUS PROTEIN PRODUCTION | UNIV GUELPH (CA) | 2026-02-19 | — | — | US | disclosed |
| EP-4638779-A1 | STERILISED APPARATUS FOR CAPTURING NUCLEIC ACIDS FROM BODY FLUIDS | Biocaptiva Limited (GB) | 2025-10-29 | — | — | EP | disclosed |
| WO-2025217257-A1 | ENGINEERED CIRCULARIZED PEGRNAS AND USES THEREOF | TRUSTEES OF BOSTON UNIVERSITY (US) | 2025-10-16 | — | — | WO | disclosed |
| EP-4615994-A1 | DNAZYME FOR EOSINOPHIL PEROXIDASE AND USES THEREOF | McMaster University (CA) | 2025-09-17 | — | — | EP | disclosed |
| WO-2025085704-A1 | BRAIN-CELL SPECIFIC PARTIAL CELLULAR REPROGRAMMING TREATMENT AND PREVENTION METHODS FOR ALZHEIMER'S DISEASE AND PROGERIA, COMPOSITIONS THEREFORE, AND USES THEREOF | YOUTHBIO THERAPEUTICS INC. (US) | 2025-04-24 | — | — | WO | disclosed |
| CN-1229084-A | Unsaturated phosphate derivatives of purines and pyrimidines | MERRELL DOW PHARMA (US) | 1999-09-22 | — | — | CN | disclosed |
| CN-1212693-A | Process for preparing purine derivatives | HOFFMANN LA ROCHE (CH) | 1999-03-31 | — | — | CN | disclosed |
| CN-1192154-A | Combinatorial libraries of substrate-bound cyclic organic compounds | CHIRON CORP (US) | 1998-09-02 | — | — | CN | disclosed |
| CN-1120338-A | Unsaturated phosphonate derivatives of purines and pyrimidines | MERRELL DOW PHARMA (US) | 1996-04-10 | — | — | CN | disclosed |
| US-5412088-A | 6-O-substituted guanosine derivatives | RUTGERS, THE STATE UNIVERSITY (US) | 1995-05-02 | — | — | US | disclosed |
| CN-1036578-A | NOVEL FLUOROPHOSPHONATE NUCLEOTIDE DERIVATIVES | MERRELL DOW PHARMA (US) | 1989-10-25 | — | — | CN | disclosed |
| EP-0310365-A1 | Engine seal compatible dispersant for lubricating oils | AMOCO CORPORATION (US) | 1989-04-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260049318-A1 | INHIBITION OF PLANT PROTEASE AED3-1 FOR IMPROVED HETEROLOGOUS PROTEIN PRODUCTION | DPP3, IDE, NOTCH3 | GDA 495/4885PNP 1073/4885XDH 4554/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.